Direct oral anticoagulant (DOAC) levels, bleeding, and breakthrough thrombosis: fog of war
Journal of Thrombosis and Haemostasis · 2025-11 · 23 (11) · 3441-3444
DOI: 10.1016/j.jtha.2025.08.003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Thrombosis and Haemostasis, 2025-11. Verfasst von Joseph R Shaw. Beteiligte Einrichtung: Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada; Inflammation and Chronic Disease Program, Division of Hematology, Ottawa Hospi…. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 21 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada; Inflammation and Chronic Disease Program, Division of Hematology, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada. Electronic address: j…
Zitieren
APA
Shaw, J. R. (2025). Direct oral anticoagulant (DOAC) levels, bleeding, and breakthrough thrombosis: fog of war. Journal of Thrombosis and Haemostasis, 23(11), 3441-3444. https://doi.org/10.1016/j.jtha.2025.08.003
Vancouver
Shaw JR. Direct oral anticoagulant (DOAC) levels, bleeding, and breakthrough thrombosis: fog of war. Journal of Thrombosis and Haemostasis. 2025;23(11):3441-3444. doi:10.1016/j.jtha.2025.08.003
BibTeX
@article{Shaw2025,
author = {Shaw, Joseph R},
title = {Direct oral anticoagulant (DOAC) levels, bleeding, and breakthrough thrombosis: fog of war},
journal = {Journal of Thrombosis and Haemostasis},
year = {2025},
volume = {23},
number = {11},
pages = {3441--3444},
doi = {10.1016/j.jtha.2025.08.003}
}
EUVIMED